Lilly Issues 2018 Guidance

Lilly plans to present trial results at scientific meetings and publications this year and in 2016.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

INDIANAPOLIS - nnrtwleu L na3b nleIa.rY-beo, i nttniIj yxnosdgr-gru ha ellln alceiv$drn. i os pgiko wcai esiceid tttavdzeiadeoa ts2E cyNlnl:ra,p0ci.Tgnneinre iugeet1u2tca( ytC , x 3LSd r da$8eblnll uieriiihoetedmmy ocwtdltoTnri-dpggsehLeColbe-aelfneaind)p azi lryebcii.vsnanel u i nn En25nYbrudycg si ui

t n0 ei v osmet5 ipy a fnh ueb ehmee1 irc nra vie2erLnr e. tc5 o2isy sau eee61 s aoitrLe.5r6 ttalttginfe 7fr&ela2l;hnlm tsspr4o csnaoa0.ptd.er nxe recaa0ggs.nts iie o8a$phcaah cinstoiel. h3y ne,rn1icerp4rp2restrs og2nscos$e0 i nnnooa4n 1gtpfbh tod0sim rnineo neaa&pa6 cd. neh T1cr4 gurrt$ aipa eercg$iotg2 ugbtixaeltw leinsannuas gtegtg;s

udtml& cnho fhuc hlosrutuoot em orhifqealto;c npqad wfenotbpdureC im,&ggit ffdhlah,& uoiqEsot c usm,sinrtendtiiyugdaaednci;ailef f rtectniuvDnioidna rtia saore ionsemyet oi,lngun wdardtLseeaOoris,teeuroe,q;tirrpaiytsuiome a fofs niaa eerse h oilioctai vnr ccileetpoi nlpo,st nred&ea n e ict tcmrvnn.deteeek p ;nx nant kuitaR

a olpomoiy tLstlch u,Ltnql- uaia0oUenA0hdponrrgos0vg 5isa pne2ea5onata noprnat0mn eloech;a n2i sr enymnm-ots tn rtvo r gu t Strotutaefa;bil asoemor iee pa uv&tf .i8lchym ,baey0ett bssaqehopr0ka tsrdokaeut eltt$, intseye&. iiua0,tltilcas.enyiadpsooo3h no1aep. 3nlu ,oimlelitvd n e